User:Isabela Fonseca de Oliveira Granha/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 25: Line 25:
==The ß-catenin destruction complex==
==The ß-catenin destruction complex==
-
In baseline conditions without Wnt signaling, ß-catenin concentrations are low in both the cytoplasm and the nucleus. Then, the destruction complex (Figure 2), formed by APC, [[Axin]], CK1ɑ and [[Glycogen synthase kinase 3|GSK]], is active and causes the degradation of the protein through proteasome. Initially it is recognized by APC and [[Axin]] that promote the phosphorylation of Ser45 by CK1ɑ. This facilitates the phosphorylation by [[Cyclin-dependent kinase|GSK]] in the residues of the amino acids Thr41, Ser37 and Ser33. The last two, when phosphorylated, leads to recognition by ß-TrCP and consequently ubiquitination by an [[Ubiquitin protein ligase|E3 ligase]] and degradation by [[Proteasome|26S proteasome]]. <ref name="valenta2012" /> Furthermore, the relation Wnt/ß-catenin pathway usually are reported by 'canonical' and 'non-canonical', whose meaning remotes to the components of the cascate. The first leads to accumulation and stabilization of cytosolic (unphosphorylated) ß-catenin and the second promotes the increase in intracellular calcium or mediate cell polarity, but both are established in embryonic development of normal tissue and organs. <ref name=Arend ''et al''2013></ref>Arend ''et al,''2013.The Wnt/β-catenin pathway in ovarian cancer: A review. Gynecologic Oncology. Volume 131, Issue 3, December 2013, Pages 772-779.</ref> <ref name=Takayama ''et al''1996>Takayama ''et al,'' 1996. ß-Catenin Expression in Human Cancers. American journal of Pathology, Vol. 148, No. 1, January. </ref>
+
In baseline conditions without Wnt signaling, ß-catenin concentrations are low in both the cytoplasm and the nucleus. Then, the destruction complex (Figure 2), formed by APC, [[Axin]], CK1ɑ and [[Glycogen synthase kinase 3|GSK]], is active and causes the degradation of the protein through proteasome. Initially it is recognized by APC and [[Axin]] that promote the phosphorylation of Ser45 by CK1ɑ. This facilitates the phosphorylation by [[Cyclin-dependent kinase|GSK]] in the residues of the amino acids Thr41, Ser37 and Ser33. The last two, when phosphorylated, leads to recognition by ß-TrCP and consequently ubiquitination by an [[Ubiquitin protein ligase|E3 ligase]] and degradation by [[Proteasome|26S proteasome]]. <ref name="valenta2012" /> Furthermore, the relation Wnt/ß-catenin pathway usually are reported by 'canonical' and 'non-canonical', whose meaning remotes to the components of the cascate. The first leads to accumulation and stabilization of cytosolic (unphosphorylated) ß-catenin and the second promotes the increase in intracellular calcium or mediate cell polarity, but both are established in embryonic development of normal tissue and organs. <ref name=Arend ''et al''2013> Arend ''et al,''2013. The Wnt/β-catenin pathway in ovarian cancer: A review. Gynecologic Oncology. Volume 131, Issue 3, December 2013, Pages 772-779.</ref> <ref name=Takayama ''et al''1996>Takayama ''et al,'' 1996. ß-Catenin Expression in Human Cancers. American journal of Pathology, Vol. 148, No. 1, January. </ref>
[[Image:Axindestructioncomplex.png]]
[[Image:Axindestructioncomplex.png]]

Revision as of 02:39, 22 June 2020

ß-catenin

ß-catenin is an important element in cell-cell adherens junctions, called cadherins. Reported in all Eukaryota (Eukaryota) phylum, in humans the gene CTNNB1 (CTNNB1) transcribes a 95kDa protein that allows cadherins to anchor in cytoeskeleton (actin filaments) by connecting cytoplasmic proteins. Besides that, it is an essential regulator of the canonical Wnt pathway [1] (related to embryonic development). Disturbance of this activity is associated with cancer and other diseases. Therefore, ß-catenin is an important target for developing medication for many diseases, with considerable interest in its structure. [2]

Structure of ß-catenin from Zebrafish

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Isabela Fonseca de Oliveira Granha

Personal tools